Bulls eye Tanis! Seeing the pps drop like it did from Monday's high was a bit unnerving for everyone, and the blog was very technical. You are absolutely correct. Nothing has changed here, but additional information and clarification continue to reveal a BOD, BOA, and chairman Gerald that are relentlessly driving AMBS toward world wide recognition in both diagnostics with LYMPRO and therapeutics with MANF. It is the investment opportunity of a lifetime I believe. Let's applaud Gerald and the mngt team, and prepare for some fireworks on July 31 when Gerald reveals the specifics on LYMPRO to the world. Can't wait! This is going to be one of those investment stories we'll tell our grandchildren about!
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links